The Maudsley Forum
The annual Maudsley Forum offers psychiatrists, psychologists and others interested in mental health, the opportunity to learn about the most current advances in clinical and academic psychiatry, and to meet and network with dynamic, like-minded colleagues from around the world.
The programme emphasises how research informs evidence-based clinical practice and is designed to appeal to both junior clinicians and experienced consultants. Lectures and workshops will be delivered by the best clinicians and scientists from the Institute of Psychiatry, King’s College London, and the South London and Maudsley NHS Foundation Trust.
In addition to clinical content delegates will have opportunities to discuss potential research ideas or proposals with leading academics at the Institute of Psychiatry.
This event carries 19 CPD points.
The 14th Maudsley Forum 2014
Tuesday 7th to Friday 10th October 2014
Venue: Institute of Psychiatry, Denmark Hill, London
Programme & Speakers
Fee │ Cancellation & Refund Policy │ Book Your Place
This workshop will cover two cutting edge areas of research at the opposing ends of the spectrum of neuropsychiatric practice with potentially big impacts on clinical practice beyond neuropsychiatry into both general psychiatry and general medicine. The first will be an update on the mechanism and management of conversion disorder (previously known as Hysteria). The second is an outline of the current explosion of interest in autoimmunity causing psychiatric symptoms in the context of relatively uncommon neuropsychiatric disorders (e.g. psychosis in limbic encephalitis and OCD in PANDAS).
This workshop will look at the pharmacological treatment of schizophrenia and bipolar disorder, encompassing the history of drug development, randomised trials, CNS receptors and the most effective strategies in clinical practice. Potential new targets such as nitric oxide and cannabinoids and will be discussed, as well as the reasons for the failure of glutamate compounds to reach the clinic.
Early Intervention in Psychosis
Early intervention in psychosis is becoming an integral part of mental health services in the UK and worldwide. This workshop will provide participants with an overview of the rationale and latest evidence-base for this clinical approach.
Treatment Resistance in Schizophrenia and Bipolar Disorder
Around 30% of patients with psychosis fail to respond to standard antipsychotic treatments. Clozapine is currently the only evidence based treatment for these patients, but its use is limited by adverse effects and the necessity of blood monitoring. This workshop will address four areas.
1. The epidemiology of treatment resistance
2. Prescribing clozapine including balancing of risks and benefits
3. Augmentation and alternatives to clozapine
4. Promising future treatments including stratified medicine
Further workshop details will be added shortly.
The Area │ Transport │ Accommodation
What our 2013 attendees said...
£450. The fee includes lunches, refreshments, the delegate pack with presentations, and a CPD certificate.
This year it is with great regret that we are unable to offer any financial assistance to delegates.
Cancellation & Refund Policy
Cancellation 2 months or more before the course - 100% refund
Cancellation 1-2 months or more before the course - 50% refund
Cancellation less than one month before the course - no refund
Book Your Place
“Overall excellent lectures and interesting topics.”
“The balance of subjects was right for me. I’ve been informed and inspired.”
"Good opportunity to meet the speakers and lots of time for questions.”